Literature DB >> 11250861

Registry for torsades de pointes with drug treatment exists.

M J Kilborn, R L Woosley.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11250861      PMCID： PMC1119855     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.

Authors:  Y G Yap; J Camm
Journal:  BMJ       Date:  2000-04-29
  1 in total
  5 in total

1.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 2.  Clinical and genetic determinants of torsade de pointes risk.

Authors:  Andrew J Sauer; Christopher Newton-Cheh
Journal:  Circulation       Date:  2012-04-03       Impact factor: 29.690

Review 3.  [A clinical challenge. Pragmatic treatment of migraine and concomitant depression].

Authors:  T P Jürgens; E Leinisch; H J Koch
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

4.  QTc interval in young Gujarati hypertensives: Effect of disease, antihypertensive monotherapy, and coexisting risk factors.

Authors:  Jayesh Dalpatbhai Solanki; Bhakti P Gadhavi; Amit H Makwana; Hemant B Mehta; Chinmay J Shah; Pradnya A Gokhale
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec

5.  Early Screening of Hypertension and Cardiac Dysautonomia in Each Hypertensive is Needed-inference from a Study of QTc Interval in Gujarat, India.

Authors:  Jayesh Dalpatbhai Solanki; Bhakti P Gadhavi; Amit H Makwana; Hemant B Mehta; Chinmay J Shah; Pradnya A Gokhale
Journal:  Int J Prev Med       Date:  2018-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.